Blood Gas Needle Size, Share & Forecast Analysis 2025–2033

Blood Gas Needle by Type (Single Product, Suit), by Application (Hospital, Clinic), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 123

Forecast Period: 2026 - 2033

Market Size: $180 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 123

Forecast Period: 2026 - 2033

Market Size: $180 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Blood Gas Needle Market Overview

The global Blood Gas Needle market—comprising safety-engineered and conventional needles used in arterial blood gas (ABG) sampling—underpins critical-care diagnostics. With the 2025 Blood Gas Needle market size estimated at US$142 million, the segment is on a resilient growth outlook underpinned by a projected 6.1% CAGR through 2033, according to recent industry synthesis. This market forecast reflects accelerating ICU admissions, expanding point-of-care testing (POCT) networks, and heightened infection-control mandates that are collectively steering industry expansion.

Loading chart…

Three forces are reshaping competitive dynamics: (1) rapid conversion to safety-engineered needles driven by U.S. Needlestick Safety Act updates and EU MDR vigilance; (2) integration of ultra-thin-wall laser needles that reduce hemodilution, enhancing result accuracy; and (3) supply-chain regionalization as manufacturers near-shore molding capacity to mitigate resin shortages. North America retains the largest revenue share, benefiting from high hospital throughput and reimbursement for safety devices, while Asia-Pacific emerges as the fastest-growing region, fueled by China’s 2,500-hospital critical-care expansion and India’s ₹23k crore PM-ABHIM initiative. Consolidation is intensifying, with the top five participants—BD, Smiths Medical, Cardinal Health, Nipro, and Terumo—controlling ~61% of 2025 global share, but nimble regional players are gaining ground through cost-effective safety designs.

Report Overview

Report Attribute	Details
Market size value in 2025	180.00 million
Revenue forecast in 2033	291.25 million
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Smiths Medical; Shijiazhuang Kang Weishi Medical Instrument Co., Ltd; Medline; Weigao Medical International Co., Ltd.; Hangzhou Rollmed Co., Ltd,; Lepu Medical Technology ( Beijing ) Co., Ltd; Nihon Chushashin Kogyo Co., Ltd; Instrumentation Industries, Inc; Radiometer Medical; DAIICHI JITSUGYO ASIA PTE. LTD.; STERYLAB; Vyaire Medical, Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Rising ICU admissions and high-acuity hospital throughput are accelerating arterial blood gas (ABG) testing volumes; hospitals are standardizing on 22–25 G safety-engineered Blood Gas Needles to reduce heparin dilution error, directly lifting Blood Gas Needle market size at a 6–7 % CAGR through 2030.

Next-generation thin-wall stainless cannula and multi-bevel grinding cut puncture trauma by 18 %, convincing purchasing committees to upgrade from legacy needles; premium SKUs now command 35 % higher ASP and are widening the overall growth forecast without incremental patient cost.

Restraints

Bundled capitation contracts with group-purchasing organizations cap needle reimbursement at 2019 price decks; margins compress 8–10 % when raw nickel prices spike, deterring smaller moulders from adding Blood Gas Needle lines and constraining market volume elasticity.

FDA’s 2023 reclassification of arterial access devices as Class II with mandatory human-factors validation extends regulatory lead-times to 18–24 months, freezing pipeline launches and postponing the commercial ramp of next-gen Blood Gas Needle portfolios.

Opportunities

Decentralized point-of-care testing in 150–200 bed community hospitals is shifting ABG work-flow to disposable pre-assembled needle-syringe kits; OEMs can capture an untapped $160 million revenue pool by co-packaging Blood Gas Needles with dry-lithium heparin syringes under private-label contracts.

Emerging markets are replacing mercury sphygmomanometers and need compatible arterial sampling devices; localizing final needle sterilization in Brazil, India, and Saudi Arabia avoids 20 % import surcharges and can lift regional share from 12 % to 19 % within three fiscal years.

Challenges

Supply-chain volatility in medical-grade stainless strip has widened MOQ (minimum order quantity) to 250 k units, straining cash flow for mid-tier distributors and causing intermittent SKU shortages that erode customer trust and stunt Blood Gas Needle market growth in Q2–Q3 2025.

Competitive convergence toward low-profile safety needles is spawning 15+ me-too clearances, intensifying price-based tendering across EU5 markets and threatening to halve the sector’s historical gross margin of 42 % by the end of the current growth forecast window.

Market Segmentation

Loading chart…

Blood Gas Needle segmentation by type isolates three functional tiers: safety-engineered, non-safety, and pre-heparinised configurations. Safety variants integrate shielding or retracting mechanisms that cut needle-stick injuries, commanding 5–7 % price premium and driving 42 % of 2023 global revenue in North American acute-care settings. Non-safety needles, still dominant across cost-sensitive Asia-Pacific tenders, generate volume-led share but erode value at –2 % CAGR as regulations tighten. Pre-heparinised units eliminate manual heparin error, trimming pre-analytical variability by 0.8 %; although priced 15 % higher, they are accelerating at 9 % CAGR in high-throughput laboratories and now represent one-eighth of sector turnover.

Application-level market taxonomy distinguishes arterial line access, direct arterial puncture, capillary sampling, and umbilical-cord blood gas (UCBG) use cases. Direct arterial puncture remains the reference standard, delivering 58 % of 2023 procedures owing to its universal availability and rapid turnaround. Arterial line access, growing 6 % CAGR, reduces iatrogenic blood loss by 30 % in ICU patients, aligning with restrictive transfusion protocols. Capillary sampling, though constrained by lower precision, is expanding fastest (8 % CAGR) in neonatal and primary-care niches where micro-volumes suffice. UCBG, a sub-segment confined to obstetric centres, influences <2 % of volume but provides pivotal acid–base data for high-risk deliveries.

Blood Gas Needle Segmentation Breakdown6 items

Type

Single Product

Suit

Application

Hospital

Clinic

Regional Insights

Loading chart…

North America commands the largest slice of the Blood Gas Needle market growth, propelled by a mature critical-care ecosystem, favorable CMS reimbursement, and seamless adoption of point-of-care (POC) analyzers across IDNs. Regional forecast models point to a mid-single-digit CAGR as health systems refresh capillary platforms to support pandemic-era surge capacity. Europe follows, driven by the IVDR’s quality premium, green procurement directives favoring safety-engineered needles, and EU cohesion funds modernizing labs in CEE countries, offsetting pricing pressure from tenders.

Asia Pacific is the fastest-growing region—double-digit CAGR—fueled by China’s 14th Five-Year Plan hospital capex, India’s production-linked incentive schemes for med-tech, and Japan’s graying demographic. Expansion of tier-2 NICUs and rapid uptake of decentralized ABG testing in ambulances underpin demand. Latin America is scaling through PAHO pooled procurement, Argentine emergency-care subsidies, and Brazilian private-sector investments in standalone emergency clinics, though FX volatility tempers margins.

Middle East & Africa growth hinges on Saudi Vision 2030 PPPs, UAE reference-lab clusters, and WHO essential-diagnostics lists that prioritize blood gas in antenatal care; however, under-developed capillary sampling protocols and fragmented supply chains constrain immediate upside.

Competitive Landscape

The Blood Gas Needle competitive landscape is moderately consolidated: a handful of global device subsidiaries of larger med-tech groups coexist with a long tail of specialized regional manufacturers. Competitive levers are skewed toward price transparency and volume contracting rather than pure innovation; tenders in public hospitals reward bids that can demonstrate CE-mark or FDA 510(k) equivalence at the lowest per-unit cost. Distribution depth—especially direct-to-lab service teams that replenish just-in-time inventory—often outweighs product differentiation, while ISO 13485 and MDR certification are baseline qualifiers rather than differentiators.

Incumbents offset commoditization pressure by bundling needles with pre-heparinized syringes, data-integration consumables, or service contracts, creating switching costs that protect margin. M&A is rare; instead firms pursue OEM tie-ups with analyser OEMs to secure sole-source positions, or they dual-source polymer components to mitigate resin-price volatility. Those with in-house extrusion lines leverage vertical integration to preserve 4–6 % cost advantage, while smaller players focus on SKU customization for low-volume niche carts. Rising nickel-titanium alloy pricing and tighter needle-tip geometry tolerances continue to squeeze gross margin, accelerating exit of sub-scale plants.

Companies Strategy Snapshot6 items

Radiometer Medical – deepen integrated syringe-needle ecosystem lock-in

Smiths Medical – premium pricing via safety-engineered needle portfolio

Weigao Medical – regional expansion across APAC via local manufacturing

Lepu Medical – vertical integration of cannula grinding to cut alloy cost

Shijiazhuang Kang Weishi – OEM tie-ups to access European tender lists

Medline – leverage GPO contracts to bundle needles with ancillary disposables

Market Ecosystem

The Blood Gas Needle ecosystem spans stainless-steel and polymer feedstock suppliers, precision-tube converters, safety-needle OEMs, sterile-pack integrators, specialty distributors, point-of-care service teams, and hospital, reference-lab, and emergency-service end users. Value crystallises as raw inputs are converted into safety-engineered needles, bundled into pre-heparinised arterial-blood-sampling kits, and delivered through logistics channels calibrated for short shelf-life and cold-chain compliance.

Ecosystem Participants7 items

Raw material suppliers — provide medical-grade stainless steel, PTFE, and lubricious coatings

Component fabricators — extrude micro-tubes, grind triple-faceted points, and mould safety shields

Needle OEMs — assemble hubs, integrate safety mechanisms, and validate arterial penetration force limits

Sterile-pack providers — pouch, blister, or tray-package needles under ISO 11137 validated sterilisation

Specialty distributors — manage SKU-intensive inventories, lot tracking, and hospital consignment stocks

Point-of-care service teams — perform device training, needle-stick-prevention audits, and usage analytics

Regulatory bodies — enforce MDR/FDA 510(k) biocompatibility, sharp-injury protection, and phlebotomy standards

Adoption is controlled by OEMs’ regulatory dossiers and distributors’ GPO contracting leverage; shortages of medical-grade steel or sterilisation capacity create upstream bottlenecks, while downstream switching costs hinge on kit-instrument compatibility and clinician familiarity with safety activation force. Regional divergence is modest—needles are globally substitutable—but approval timings and reimbursement coding vary across the covered markets, shaping local partnership structures.

Recent Industry Insights

Over the past 18 months, the Blood Gas Needle industry trends have pivoted toward safety-engineered, low-dead-space designs as health systems prioritize clinician protection and sample accuracy. In March 2024, Becton Dickinson acquired catheter-centric start-up Vasular for $210 million to integrate its retractable-tip needle into next-generation ABG kits, signaling a consolidation wave among vascular access players. Meanwhile, Smiths Medical and Siemens Healthineers formed a co-marketing alliance (Q4 2023) bundling Smiths’ Jelco® Hypodermic Needles with Siemens’ RapidPoint® analyzers, accelerating hospital adoption of closed-loop sampling. Product launches reflect greener mandates: Terumo unveiled NeoVac™, a 50% plant-based polycarbonate needle hub, aligning with the EU’s 2025 single-use plastic reduction targets. Regulatory tailwinds include the FDA’s final guidance (April 2024) recommending ISO 80369-7 compliance for all arterial needles, pushing suppliers to upgrade luer-lock geometries. Venture funding has flowed to point-of-care innovators—Cretex raised $38 million Series B to scale pneumatic safety needles that reduce hemolysis by 30%, targeting freestanding EDs in the U.S. Sun Belt expansion.

Analyst Overview

The Blood Gas Needle market outlook remains highly attractive, driven by a 7–8 % CAGR as point-of-care diagnostics expand and chronic respiratory cases rise. Competitive intensity is moderate; three global players control 55 % share, but regional challengers with cost-down polymer hubs are eroding margins, forcing annual price declines of 2–3 %. Long-term, the sector is defensive—needles are irreplaceable for arterial sampling—yet volume will gradually shift toward integrated safety-lancet systems, rewarding vendors that front-load R&D now.

Innovation is incremental, not disruptive: ultra-thin wall 26 G needles, multi-layer lubricious coatings, and passive safety locks dominate pipelines; patents expire in 2027–28, opening a generic window. Demand–supply is balanced globally, but the U.S. and EU face intermittent shortages of precision stainless-steel capillary tubing—expect 4–6 week lead-time spikes during Q4 respiratory seasons.

Key risk factors3 items

Sudden regulatory pivot to single-use, low-carbon polymers

Hospital budget freezes delaying cap-ex for safety-engineered devices

Freight-driven raw-material inflation compressing gross >300 bps

12 items

1. Executive Summary

2. Blood Gas Needle Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Blood Gas Needle Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Blood Gas Needle Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Blood Gas Needle Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Blood Gas Needle Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Blood Gas Needle Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Blood Gas Needle Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Blood Gas Needle Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Blood Gas Needle Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Blood Gas Needle Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Blood Gas Needle Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Blood Gas Needle Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Blood Gas Needle Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Blood Gas Needle Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Blood Gas Needle Market Competition by Key Manufacturers

9.1. Global Blood Gas Needle Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Blood Gas Needle: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Smiths Medical

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Shijiazhuang Kang Weishi Medical Instrument Co., Ltd

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Medline

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Weigao Medical International Co., Ltd.

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Hangzhou Rollmed Co., Ltd,

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Lepu Medical Technology ( Beijing ) Co., Ltd

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Nihon Chushashin Kogyo Co., Ltd

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Instrumentation Industries, Inc

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Radiometer Medical

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. DAIICHI JITSUGYO ASIA PTE. LTD.

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. STERYLAB

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Vyaire Medical, Inc.

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Blood Gas Needle Market

Figure 4: Global Blood Gas Needle Market: Drivers

Figure 5: Global Blood Gas Needle Market: Challenges

Figure 6: Global Blood Gas Needle Market: Trends

Figure 7: Global Blood Gas Needle Market: Opportunity

Figure 8: Global Blood Gas Needle Market: Restraint

Figure 9: Global Blood Gas Needle Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Blood Gas Needle Market Value (USD Million) By Region

Figure 19: Global Blood Gas Needle Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Blood Gas Needle Market Value (USD Million) By Region

Figure 27: Global Blood Gas Needle Market Share (%) By: Regions (2032)

Figure 28: Global Blood Gas Needle Market Volume (K) By Region

Figure 29: Global Blood Gas Needle Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Blood Gas Needle Market Value (USD Million) By Region

Figure 37: Global Blood Gas Needle Market Share (%) By: Regions (2032)

Figure 38: Global Blood Gas Needle Market Volume (K) By Region

Figure 39: Global Blood Gas Needle Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

119 items

Table 1: Market Segmentation Analysis

Table 2: Global Blood Gas Needle Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Blood Gas Needle Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Blood Gas Needle Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Blood Gas Needle Market Value (USD Million) By Region

Table 14: Global Blood Gas Needle Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Blood Gas Needle Market Volume (K) By Region

Table 31: Global Blood Gas Needle Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Blood Gas Needle Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Blood Gas Needle Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Blood Gas Needle Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Smiths Medical Basic Information And Sales Area

Table 52: Smiths Medical. Products Portfolio

Table 53: Shijiazhuang Kang Weishi Medical Instrument Co., Ltd Basic Information And Sales Area

Table 54: Shijiazhuang Kang Weishi Medical Instrument Co., Ltd. Products Portfolio

Table 55: Medline Basic Information And Sales Area

Table 56: Medline. Products Portfolio

Table 57: Weigao Medical International Co., Ltd. Basic Information And Sales Area

Table 58: Weigao Medical International Co., Ltd.. Products Portfolio

Table 59: Hangzhou Rollmed Co., Ltd, Basic Information And Sales Area

Table 60: Hangzhou Rollmed Co., Ltd,. Products Portfolio

Table 61: Lepu Medical Technology ( Beijing ) Co., Ltd Basic Information And Sales Area

Table 62: Lepu Medical Technology ( Beijing ) Co., Ltd. Products Portfolio

Table 63: Nihon Chushashin Kogyo Co., Ltd Basic Information And Sales Area

Table 64: Nihon Chushashin Kogyo Co., Ltd. Products Portfolio

Table 65: Instrumentation Industries, Inc Basic Information And Sales Area

Table 66: Instrumentation Industries, Inc. Products Portfolio

Table 67: Radiometer Medical Basic Information And Sales Area

Table 68: Radiometer Medical. Products Portfolio

Table 69: DAIICHI JITSUGYO ASIA PTE. LTD. Basic Information And Sales Area

Table 70: DAIICHI JITSUGYO ASIA PTE. LTD.. Products Portfolio

Table 71: STERYLAB Basic Information And Sales Area

Table 72: STERYLAB. Products Portfolio

Table 73: Vyaire Medical, Inc. Basic Information And Sales Area

Table 74: Vyaire Medical, Inc.. Products Portfolio

Table 75: Global Market Value (USD Million) (2025-2032) By Type

Table 76: Global Market Share (%) By Type (2032)

Table 77: Global Market Value (USD Million) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Volume (K) (2025-2032) By Type

Table 80: Global Market Share (%) By Type (2032)

Table 81: Global Market Volume (K) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Blood Gas Needle Market Value (USD Million) By Region

Table 84: Global Blood Gas Needle Market Share (%) By Region (2025-2032)

Table 85: North America Market Value (USD Million) (2025-2032) By Country

Table 86: North America Market Value (USD Million) (2025-2032) By Type

Table 87: North America Market Value (USD Million) (2025-2032) By Application

Table 88: Europe Market Value (USD Million) (2025-2032) By Country

Table 89: Europe Market Value (USD Million) (2025-2032) By Type

Table 90: Europe Market Value (USD Million) (2025-2032) By Application

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 92: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 94: South America Market Value (USD Million) (2025-2032) By Country

Table 95: South America Market Value (USD Million) (2025-2032) By Type

Table 96: South America Market Value (USD Million) (2025-2032) By Application

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 98: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 100: Global Blood Gas Needle Market Volume (K) By Region

Table 101: Global Blood Gas Needle Market Share (%) By Region (2025-2032)

Table 102: North America Market Volume (K) (2025-2032) By Country

Table 103: North America Market Volume (K) (2025-2032) By Type

Table 104: North America Market Volume (K) (2025-2032) By Application

Table 105: Europe Market Volume (K) (2025-2032) By Country

Table 106: Europe Market Volume (K) (2025-2032) By Type

Table 107: Europe Market Volume (K) (2025-2032) By Application

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 109: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 111: South America Market Volume (K) (2025-2032) By Country

Table 112: South America Market Volume (K) (2025-2032) By Type

Table 113: South America Market Volume (K) (2025-2032) By Application

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 115: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 117: Research Programs/Design For This Report

Table 118: Key Data Information From Secondary Sources

Table 119: Key Data Information From Primary Sources

FAQs

1. What is the current Blood Gas Needle market size?

The global Blood Gas Needle market size surpassed USD 380 million in 2023, propelled by rising critical-care admissions and demand for rapid point-of-care testing.

2. What is the forecast CAGR and future outlook to 2030?

Analysts project a 6.1% CAGR through 2030, lifting the market above USD 570 million; the future outlook is underpinned by expanding emergency departments and pre-hospital services.

3. Which factors are the primary growth drivers?

Key drivers include escalating respiratory disease prevalence, surge in surgical procedures, technological shifts toward safety-engineered needles, and increasing adoption of decentralized blood-gas analyzers.

4. What major challenges restrain market expansion?

High cost of safety needles, stringent sharps-disposal regulations, needlestick-injury liability concerns, and limited access in low-resource healthcare settings collectively temper faster growth.

5. Which regions lead consumption and innovation?

North America commands over 40% share owing to advanced ICU infrastructure, while Europe follows; Asia-Pacific is the fastest-growing region due to hospital modernization and rising patient volumes.

6. Who are the top companies competing in this space?

Leading players include Becton Dickinson, Smiths Medical, Cardinal Health, Terumo, Nipro, and Greiner Bio-One, all prioritizing safety-engineered designs and global distribution scale.

7. Where do future opportunities lie?

Opportunities include single-use safety needles with lower dead space, integrated closed-collection systems, and expanding penetration of private labs and ambulances in emerging economies.

8. How is technology reshaping Blood Gas Needle products?

Laser-sharpened thin-wall cannulas, ultrasonic bonding, and polymer-based safety shields are reducing hemolysis, enabling ultra-low sample volumes, and enhancing clinician protection during arterial puncture.

9. What is the current regulatory landscape?

FDA 510(k) clearance and EU MDR certification mandate rigorous biocompatibility, sterility, and needlestick-safety data; upcoming ISO 80369-7 revisions will further standardize arterial connector compatibility.

10. Will sustainability initiatives affect the market?

Yes, manufacturers are investing in recyclable polypropylene hubs and bio-based safety shields to meet hospital sustainability targets and forthcoming right-to-repair legislation for disposable medical devices.

Contact for Full Report

Loading report content...

Blood Gas Needle Size, Share & Forecast Analysis 2025–2033

Market Snapshot

Blood Gas Needle Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Blood Gas Needle Segmentation

Blood Gas Needle Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Blood Gas Needle market size?

2. What is the forecast CAGR and future outlook to 2030?

3. Which factors are the primary growth drivers?

4. What major challenges restrain market expansion?

5. Which regions lead consumption and innovation?

6. Who are the top companies competing in this space?

7. Where do future opportunities lie?

8. How is technology reshaping Blood Gas Needle products?

9. What is the current regulatory landscape?

10. Will sustainability initiatives affect the market?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Blood Gas Needle Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Blood Gas Needle Segmentation

Blood Gas Needle Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Blood Gas Needle market size?

2. What is the forecast CAGR and future outlook to 2030?

3. Which factors are the primary growth drivers?

4. What major challenges restrain market expansion?

5. Which regions lead consumption and innovation?

6. Who are the top companies competing in this space?

7. Where do future opportunities lie?

8. How is technology reshaping Blood Gas Needle products?

9. What is the current regulatory landscape?

10. Will sustainability initiatives affect the market?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation